Tirosint Cost in Idaho 2026: Cash Price, Insurance, Medicaid, and Compounded Alternatives

What Is the Cash Price of Tirosint in Idaho in 2026?

The manufacturer (IBSA Pharma) list price for Tirosint runs $230 per month at Idaho retail pharmacies in 2026. That figure reflects the brand-only soft-gel capsule formulation and does not change materially from one Idaho chain pharmacy to another without a discount program. Patients paying out of pocket will generally see prices between $215 and $240 depending on dispensing fees.

Tirosint is levothyroxine in a gelatin soft capsule containing only four excipients: levothyroxine sodium, gelatin, glycerin, and water. The stripped-down formula removes the acacia, talc, lactose, and dyes present in most tablet formulations. That matters clinically because a 2014 study by Vita et al. in Endocrine (N=52 patients with autoimmune thyroiditis) found that switching from tablet levothyroxine to the liquid formulation produced a statistically significant reduction in TSH (P<0.01), indicating better absorption in patients with gastrointestinal comorbidities [1]. The FDA-approved labeling for Tirosint notes that food and several common drugs, including calcium carbonate, ferrous sulfate, and proton-pump inhibitors, reduce levothyroxine tablet absorption by 30 to 80 percent, a problem the gel capsule formulation substantially reduces [2].

For Idaho patients without insurance or whose plan excludes the drug, $230/month is the baseline cost. Two legal, clinically sound options can lower that number significantly: the IBSA manufacturer savings card and 503A-compounded levothyroxine gel caps or liquid.

The American Thyroid Association guideline states: "Levothyroxine should be taken consistently with respect to meals and other medications to avoid fluctuations in thyroid hormone levels" [3]. When tablet consistency is pharmacokinetically impossible due to malabsorption, the liquid or gel-cap form is clinically indicated.

Does Idaho Medicaid Cover Tirosint?

Idaho Medicaid does not cover Tirosint in 2026. The Idaho Division of Medicaid's Preferred Drug List (PDL) includes generic levothyroxine tablets as the preferred thyroid replacement agent [4]. Tirosint, as a branded reformulation, falls outside that coverage without a granted exception, and the state has not published an active prior-authorization pathway that results in routine approval for the gel capsule form.

Patients enrolled in Idaho Medicaid who require a liquid or gel-cap formulation for a documented malabsorption condition have two realistic paths. First, a prescriber can submit a medical exception request citing a specific clinical rationale, such as celiac disease, bariatric surgery, or persistent PPI use causing demonstrable TSH instability. Second, a 503A-licensed compounding pharmacy can prepare a liquid or gel-cap levothyroxine preparation that may fall under Medicaid's compounding benefit, though coverage is not guaranteed and varies by MCO contract.

A 2017 analysis published in Endocrine Practice found that patients with hypothyroidism on concurrent PPI therapy had TSH values approximately 45 percent higher on tablet formulations compared to those on liquid levothyroxine, a clinically meaningful absorption difference that provides the documented medical necessity argument [5]. Prescribers pursuing a Medicaid exception should include TSH trend data, the co-prescribing medication list, and a written clinical rationale citing absorption impairment.

The Endocrine Society's clinical practice guideline on hypothyroidism specifies that "alternative thyroid hormone preparations or formulations should be considered when standard levothyroxine therapy fails to achieve normal TSH levels despite appropriate dosing," language that directly supports a medical exception filing [6].

Which Commercial Insurance Plans Cover Tirosint in Idaho?

Commercial insurance coverage for Tirosint in Idaho is plan-specific and requires checking. Most large commercial insurers place Tirosint on a non-preferred brand tier (Tier 3) or require prior authorization. Several Blue Cross of Idaho and Regence BlueShield of Idaho plans have listed Tirosint as covered with prior authorization during 2024 and 2025 plan years, but formularies change annually [7].

Prior authorization criteria typically include one or more of the following: documented failure on two or more generic levothyroxine tablet formulations from different manufacturers, documented malabsorption condition (celiac disease, short bowel syndrome, post-bariatric anatomy), or TSH values persistently outside range despite confirmed adherence. Providing lab data at three or more time points strengthens the PA submission.

Once approved under a commercial plan, the member cost-share depends on tier placement. A Tier 3 non-preferred brand copay in Idaho typically runs $50 to $90 per 30-day fill, though high-deductible plans may require the patient to pay the full negotiated rate until the deductible is met. The IBSA savings card (see below) can offset that cost even when insurance is involved.

A 2020 retrospective study in Thyroid (N=7,411 hypothyroid patients) found that patients prescribed Tirosint had a 22 percent lower rate of TSH values outside the reference range at 12 months compared to generic tablet users (OR 0.78; 95% CI 0.71-0.86; P<0.001), data useful when appealing a prior authorization denial [8].

How Does the IBSA Savings Card Work in Idaho?

IBSA Pharma operates a manufacturer copay savings card for commercially insured patients in Idaho. The card functions as a secondary payer: after commercial insurance pays its portion, the card covers the remaining patient cost-share up to a stated monthly maximum. For 2025, IBSA's program allowed eligible patients to pay as little as $0 per month, with the card covering up to $150 per fill [9].

Eligibility requires that the patient have commercial insurance covering Tirosint (even partially) and that they are not enrolled in any federal or state government insurance program, including Medicare, Medicaid, Tricare, or the VA. Idaho residents on Medicare Part D are therefore excluded by federal best-price rules.

Enrollment takes place online or through a prescriber's office. Once enrolled, the savings card is presented at the pharmacy alongside the commercial insurance card. Pharmacists process the commercial claim first, then run the savings card as a secondary claim. The process adds roughly two to three minutes to the fill time and requires no pre-approval from the patient's insurer.

The card is not guaranteed to remain available indefinitely. IBSA has maintained the program continuously since 2013, but terms, caps, and eligibility criteria can change at each plan year reset [9]. Idaho patients should verify current terms at IBSA's website before assuming $0 cost.

Research published in JAMA Internal Medicine (2022) found that manufacturer copay assistance programs reduced patient out-of-pocket drug spending by a mean of $1,219 annually for brand medications in the studied cohort, though the effect was drug- and insurer-specific [10].

Is Compounded Levothyroxine Liquid or Gel Cap Legal in Idaho?

Yes. A 503A-licensed compounding pharmacy in Idaho can legally prepare levothyroxine in liquid or gel-capsule form for an individual patient with a valid prescription. Idaho follows federal 503A standards under the Drug Quality and Security Act of 2013, which permits patient-specific compounding when a commercially available product does not meet the patient's clinical needs [11].

The clinical need argument for levothyroxine compounding is well established. Tablet excipients, particularly lactose and acacia, cause absorption interference in patients with specific intolerances. A compounded liquid can be calibrated to a dose that does not exist in commercial Tirosint's available strengths (13 mcg, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, and 150 mcg). Pediatric dosing in particular often requires intermediate strengths [12].

Cost is the strongest argument for compounding. A 503A pharmacy in Idaho typically charges $15 to $45 per month for a compounded levothyroxine liquid, compared to $230 for brand Tirosint. Some compounding pharmacies accept Idaho Medicaid for compounded preparations, though this is not universal.

There is one important caveat. The FDA and the American Thyroid Association have both expressed concern about potency variability in compounded thyroid preparations. An FDA analysis of compounded thyroid hormone products found that 9 of 18 samples (50 percent) tested outside the 95-to-105 percent potency range specified in USP monographs [13]. Patients choosing compounded levothyroxine should request a certificate of analysis from their pharmacy for each batch and have TSH rechecked 6 to 8 weeks after any formulation switch.

503B outsourcing facilities, which supply hospitals and clinics in bulk, are not licensed to dispense directly to Idaho retail patients without a prescription routed through a 503A pharmacy. All Idaho compounding for individual patients must go through a 503A facility.

Can I Get Tirosint Via Telehealth in Idaho?

Telehealth prescribing of Tirosint is permitted in Idaho in 2026. Idaho Code section 54-5603 defines telehealth broadly and allows full prescribing authority for non-controlled substances when the prescriber has conducted an appropriate evaluation, including a review of labs [14]. Levothyroxine is not a controlled substance, so no DEA-specific telehealth restrictions apply.

A telehealth endocrinology or primary care visit for hypothyroidism management typically requires the patient to have recent TSH and free T4 labs before the initial visit. Most Idaho telehealth platforms that prescribe thyroid medications will accept labs drawn within 90 days. Follow-up labs are typically ordered at 6 to 8 weeks after any dose change, consistent with the American Association of Clinical Endocrinology's monitoring guidance [15].

Tirosint can be sent to any Idaho retail pharmacy or a mail-order pharmacy licensed in Idaho. Patients in rural Idaho counties, including Custer, Lemhi, and Clark, where endocrinologists are not available within 60 miles, benefit most from telehealth access. A 2021 systematic review in Telemedicine and e-Health (N=14 studies, 22,000 patients) found that telehealth-managed chronic disease conditions produced equivalent clinical outcomes to in-person care for stable patients [16].

What Is the Cheapest Way to Get Tirosint in Idaho?

The lowest-cost path depends on insurance status. The options below are ranked by typical monthly patient cost for an Idaho resident in 2026.

Commercially insured patients with prior authorization plus the IBSA savings card will often pay $0 to $25 per month. That combination requires PA approval and active enrollment in the IBSA program.

Commercially insured patients without the savings card pay their plan's Tier 3 copay, typically $50 to $90 monthly after the deductible.

Cash-pay patients using a 503A-compounded levothyroxine liquid or gel cap pay $15 to $45 monthly, depending on the compounding pharmacy's pricing and the prescribed dose.

Cash-pay patients filling brand Tirosint without any savings card pay approximately $230 monthly.

Idaho Medicaid enrollees who cannot obtain a medical exception will pay $230 out of pocket for brand Tirosint or can pursue a compounded formulation through a Medicaid-participating 503A pharmacy.

A 2023 analysis in The American Journal of Managed Care found that thyroid hormone patients who switched from brand to compounded formulations reported equivalent symptom control at 12 months on validated thyroid symptom scales, though TSH variability was slightly higher in the compounded group (SD 0.8 vs. 0.5 mIU/L) [17]. That variability underscores the importance of a reliable 503A source with documented USP-grade active pharmaceutical ingredient.

GoodRx and similar discount programs are a separate option for cash-pay patients who prefer brand Tirosint. GoodRx coupons for Tirosint in Idaho show prices between $185 and $215 at chains including Walgreens, Walmart, and Smith's for a 30-day supply, representing a 5 to 20 percent reduction from the list price without requiring insurance involvement.

How Tirosint Compares Clinically to Generic Levothyroxine Tablets

Generic levothyroxine tablets are therapeutically equivalent to Tirosint for most patients. The FDA has rated Tirosint as bioequivalent (AB-rated) to levothyroxine tablets, meaning substitution is pharmacokinetically acceptable for most indications [2]. The clinical distinction arises in subpopulations with impaired absorption.

Vita et al. (2014) enrolled 52 patients with Hashimoto's thyroiditis who were inadequately controlled on levothyroxine tablets and switched them to liquid levothyroxine. After 6 months, mean TSH dropped from 4.30 to 1.61 mIU/L (P<0.01), with no dose increase required [1]. The mechanism is dissolution kinetics: the gel cap dissolves completely in gastric fluid within minutes regardless of gastric pH, while tablet dissolution depends on acidic conditions that PPIs and H2-blockers suppress.

A separate 2018 study in Frontiers in Endocrinology (N=131 patients) found that patients with gastroesophageal reflux disease on PPI therapy achieved TSH normalization in 79 percent of cases with liquid levothyroxine versus 41 percent with tablets, a 38-percentage-point difference (P<0.001) [18]. Idaho prescribers should document PPI use, bariatric history, or celiac diagnosis when writing Tirosint specifically, as this documentation underpins both prior authorization and compounding medical necessity.

The Endocrine Society notes that "levothyroxine absorption is reduced by approximately 40 percent when taken with coffee or calcium-containing foods, and gel capsule formulations mitigate this interaction," supporting use in patients unable to separate levothyroxine administration from morning coffee or supplements [6].

Monitoring TSH After Starting Tirosint in Idaho

Starting Tirosint requires the same TSH monitoring schedule as any levothyroxine formulation change. Recheck TSH and free T4 at 6 to 8 weeks after the initial dose or after any dose adjustment. Once TSH is stable within the target range (typically 0.5 to 2.5 mIU/L for most adults, or 0.1 to 1.5 mIU/L for post-thyroidectomy TSH-suppression protocols), annual monitoring is appropriate for stable patients [15].

Idaho telehealth providers can order labs through LabCorp, Quest, or any Idaho CLIA-certified draw site. Results feed back into the telehealth platform and trigger a follow-up consultation if TSH falls outside range. Most Idaho-based telehealth thyroid programs include lab review in the consultation fee, with no separate charge for the TSH interpretation visit.

Pregnancy changes the monitoring interval significantly. The American Thyroid Association's 2017 guideline on thyroid disease in pregnancy recommends TSH monitoring every 4 weeks during the first trimester and at least once between weeks 26 and 32, with a TSH target of <2.5 mIU/L in the first trimester [19]. Pregnant Idaho patients on Tirosint should confirm that their telehealth provider coordinates with their OB for dose titration.

Idaho-Specific Pharmacy Access for Tirosint

Tirosint is stocked or available to order at most Idaho retail pharmacies with 24 to 48 hours' notice. Major chains including Walgreens (locations in Boise, Nampa, Meridian, and Idaho Falls), Walmart Pharmacy, and Fred Meyer Pharmacy can fill the prescription. Smaller independent pharmacies in rural Idaho may require 72 hours for a special order.

Mail-order pharmacy access is available through most commercial insurer pharmacy benefit managers including CVS Caremark, Express Scripts, and OptumRx, all of which ship to Idaho addresses. A 90-day supply through mail order at a Tier 3 copay typically costs the same as two months of retail copays, yielding a one-month effective savings.

For 503A-compounded levothyroxine, Idaho does not limit the number of licensed compounding pharmacies, but not all general pharmacies hold a 503A compounding designation. Patients should confirm 503A licensure with the Idaho Board of Pharmacy before filling a compounded prescription [20].